CA3254872A1 - BIOFUNCTIONAL PEPTIDE WITH MUCOADHESIVE AND VIRUS-BINDING PROPERTIES - Google Patents

BIOFUNCTIONAL PEPTIDE WITH MUCOADHESIVE AND VIRUS-BINDING PROPERTIES

Info

Publication number
CA3254872A1
CA3254872A1 CA3254872A CA3254872A CA3254872A1 CA 3254872 A1 CA3254872 A1 CA 3254872A1 CA 3254872 A CA3254872 A CA 3254872A CA 3254872 A CA3254872 A CA 3254872A CA 3254872 A1 CA3254872 A1 CA 3254872A1
Authority
CA
Canada
Prior art keywords
mucoadhesive
binding properties
virus binding
bifunctional peptide
bifunctional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3254872A
Other languages
English (en)
French (fr)
Inventor
Daniel Lauster
Robyn DIEHN
Tatyana POVOLOTSKY
Markus BARDUA
Christian Hackenberger
Sebastian FLOREZ
Jan Maly
Andreas Herrmann
Original Assignee
Forschungsverbund Berlin FVB eV
Freie Universitaet Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forschungsverbund Berlin FVB eV, Freie Universitaet Berlin filed Critical Forschungsverbund Berlin FVB eV
Publication of CA3254872A1 publication Critical patent/CA3254872A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/17—Metallocarboxypeptidases (3.4.17)
    • C12Y304/17023—Angiotensin-converting enzyme 2 (3.4.17.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA3254872A 2022-04-01 2023-03-31 BIOFUNCTIONAL PEPTIDE WITH MUCOADHESIVE AND VIRUS-BINDING PROPERTIES Pending CA3254872A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22166380.0 2022-04-01
EP22166380 2022-04-01
PCT/EP2023/058432 WO2023187142A1 (en) 2022-04-01 2023-03-31 Bifunctional peptide with mucoadhesive and virus binding properties

Publications (1)

Publication Number Publication Date
CA3254872A1 true CA3254872A1 (en) 2023-10-05

Family

ID=81448252

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3254872A Pending CA3254872A1 (en) 2022-04-01 2023-03-31 BIOFUNCTIONAL PEPTIDE WITH MUCOADHESIVE AND VIRUS-BINDING PROPERTIES

Country Status (8)

Country Link
US (1) US20250250312A1 (https=)
EP (1) EP4504342B1 (https=)
JP (1) JP2025514630A (https=)
KR (1) KR20240166574A (https=)
CN (1) CN119677782A (https=)
AU (1) AU2023246944A1 (https=)
CA (1) CA3254872A1 (https=)
WO (1) WO2023187142A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4684804A1 (en) 2024-07-26 2026-01-28 Freie Universität Berlin Conjugation product comprising an antigen binding moiety and a mucin binding moiety

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021190980A1 (en) * 2020-03-22 2021-09-30 Quadrucept Bio Limited Multimers for viral strain evolution
WO2021257781A1 (en) * 2020-06-19 2021-12-23 Vast Sea Biotechnology, Inc. Compositions and methods for treating covid-19

Also Published As

Publication number Publication date
WO2023187142A1 (en) 2023-10-05
CN119677782A (zh) 2025-03-21
JP2025514630A (ja) 2025-05-09
AU2023246944A1 (en) 2024-10-10
EP4504342B1 (en) 2026-04-29
US20250250312A1 (en) 2025-08-07
KR20240166574A (ko) 2024-11-26
EP4504342A1 (en) 2025-02-12

Similar Documents

Publication Publication Date Title
CA3254872A1 (en) BIOFUNCTIONAL PEPTIDE WITH MUCOADHESIVE AND VIRUS-BINDING PROPERTIES
EP4141020A4 (en) NOVEL CELL-PENETRATING PEPTIDE AND USE THEREOF
EP4306539A4 (en) Anti-varicella-zoster virus antibodies and their use
EP4269428A4 (en) NEW PEPTIDE AND ITS USE
EP4163288A4 (en) NEW NUCLEOLIN-BINDING PEPTIDE AND USE THEREOF
EP4286520A4 (en) Antigen-binding protein and use thereof
EP4132554A4 (en) PEPTIDES AGAINST OBESITY AND THEIR USES
CA3305225A1 (en) Viral peptides and uses thereof
HK40111663A (en) Recombinant glycan binding proteins and its use
AU2023902602A0 (en) Peptide conjugates and uses thereof
HK40121188A (en) Siglec-8 binding proteins and uses thereof
CA3303836A1 (en) Bifunctional proteins and uses thereof
CA3265178A1 (en) Antigen-binding proteins and their uses
AU2021903864A0 (en) Improved binding proteins and uses thereof
HK40113395A (en) Antigen binding proteins and uses thereof
HK40111162A (en) Stapled peptide and use thereof
AU2020904623A0 (en) Improved binding proteins and uses thereof
CA3277627A1 (en) Peptide and use thereof
AU2023465316A1 (en) Recombinant antibodies and uses thereof
CA3273760A1 (en) Dual function proteins and uses thereof
CA3279968A1 (en) Antigen binding protein and use thereof
CA3276479A1 (en) Stapled peptides and methods thereof
CA3277014A1 (en) Stapled peptides and methods thereof
HK40106457A (en) Isolated polypeptide and use thereof
EP4073108B8 (en) Virus and antigen purification and conjugation

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT

Effective date: 20240925

A15 Pct application entered into the national or regional phase

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250319

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250319

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250320

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250328

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250328

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260305

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260305